Drug Delivery

Failure to launch sparks need for an independent design review

The Challenge

Identifying the root cause of issues for an insulin pump that needed to launch to market

 

Our Approach

A well-known pharmaceutical company had recently acquired the intellectual property for a wearable insulin pump but, due to a variety of factors, the device was not ready to market, even after years of development. They asked Sanner to conduct an independent design review to ascertain where the device was falling short of critical requirements for launch.

 

The Result

We provided a fresh set of experienced eyes and brains on this project in order to identify and manage risks for our client. Our experience with device design and working with manufacturers put us in a perfect position to offer impartial advice.

We were able to identify and rank technical design and manufacturing risks and conducted in-depth technical investigations. The progress against key recommendations were monitored by Sanner over the following months to ensure successful resolution and as a result, the product went to market.

Gilero News

Gilero, a Sanner Group Company, starts manufacturing in Greensboro, USA

Life at Gilero

Completing a Graduate Degree while Working at Gilero

Manufacturing

The Importance of Current Good Manufacturing Practices (cGMPs) in Medical Device Manufacturing

General

Heuristic Analysis: An Alternative to Formative Usability Testing  

Gilero News

Sanner Group Acquires Gilero to Expand its Global Medical Device Offering

Drug Delivery

Developing a Simpler Nasal Vaccine Administration Device for Infants

Drug Delivery

Beyond Borders: How geopolitical shifts are redefining pharma and medical device development